TFG

trafficking from ER to golgi regulator

Basic information

Region (hg38): 3:100709295-100748964

Links

ENSG00000114354NCBI:10342OMIM:602498HGNC:11758Uniprot:Q92734AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • hereditary motor and sensory neuropathy, Okinawa type (Supportive), mode of inheritance: AD
  • hereditary spastic paraplegia 57 (Supportive), mode of inheritance: AR
  • autosomal dominant Charcot-Marie-Tooth disease type 2 due to TFG mutation (Supportive), mode of inheritance: AD
  • hereditary motor and sensory neuropathy, Okinawa type (Strong), mode of inheritance: AD
  • hereditary spastic paraplegia 57 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Neuropathy, hereditary motor and sensory, Okinawa type; Spastic paraplegia 57ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingMusculoskeletal; Neurologic17906970; 22883144; 23479643; 23553329; 25098539

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TFG gene.

  • Hereditary motor and sensory neuropathy, Okinawa type;Hereditary spastic paraplegia 57 (2 variants)
  • Hereditary spastic paraplegia 57 (1 variants)
  • not provided (1 variants)
  • Inborn genetic diseases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TFG gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
79
clinvar
3
clinvar
84
missense
2
clinvar
1
clinvar
170
clinvar
5
clinvar
1
clinvar
179
nonsense
1
clinvar
5
clinvar
6
start loss
0
frameshift
3
clinvar
3
inframe indel
2
clinvar
2
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
7
17
4
28
non coding
1
clinvar
50
clinvar
37
clinvar
88
Total 2 2 184 134 41

Highest pathogenic variant AF is 0.00000657

Variants in TFG

This is a list of pathogenic ClinVar variants found in the TFG region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
3-100709442-G-T not specified Benign (Apr 26, 2015)378883
3-100709467-AT-A Benign (Feb 20, 2020)1280370
3-100709512-A-G Benign (Jun 16, 2021)1291855
3-100709616-G-C Benign (Jun 20, 2018)670587
3-100709800-T-C Benign (Feb 21, 2020)1257482
3-100713482-A-G Likely benign (Sep 18, 2018)1212654
3-100713570-CATCTA-C Benign (Sep 30, 2021)1301296
3-100713641-AG-A Uncertain significance (Jan 09, 2024)423136
3-100713691-C-T Hereditary motor and sensory neuropathy, Okinawa type;Hereditary spastic paraplegia 57 Likely benign (Aug 10, 2023)1111154
3-100713694-AC-GA Hereditary motor and sensory neuropathy, Okinawa type;Hereditary spastic paraplegia 57 Uncertain significance (Feb 07, 2020)1009525
3-100713702-A-C Hereditary motor and sensory neuropathy, Okinawa type;Hereditary spastic paraplegia 57 Uncertain significance (Nov 09, 2022)2941433
3-100713709-T-C Hereditary spastic paraplegia 57;Hereditary motor and sensory neuropathy, Okinawa type Likely benign (Apr 14, 2023)1610067
3-100713709-T-G Uncertain significance (Jun 08, 2017)432643
3-100713710-G-A Hereditary spastic paraplegia 57;Hereditary motor and sensory neuropathy, Okinawa type Uncertain significance (Sep 08, 2022)1425621
3-100713718-A-T Hereditary motor and sensory neuropathy, Okinawa type;Hereditary spastic paraplegia 57 Likely benign (Apr 08, 2023)2943284
3-100713719-A-G Hereditary spastic paraplegia 57;Hereditary motor and sensory neuropathy, Okinawa type • Inborn genetic diseases Uncertain significance (Mar 05, 2020)1054786
3-100713722-A-G Hereditary motor and sensory neuropathy, Okinawa type;Hereditary spastic paraplegia 57 Uncertain significance (May 30, 2022)624218
3-100713738-G-C Hereditary spastic paraplegia 57;Hereditary motor and sensory neuropathy, Okinawa type Uncertain significance (May 18, 2022)2158429
3-100713742-G-A Hereditary motor and sensory neuropathy, Okinawa type;Hereditary spastic paraplegia 57 Likely benign (Oct 14, 2021)765652
3-100713746-A-G Hereditary motor and sensory neuropathy, Okinawa type;Hereditary spastic paraplegia 57 Uncertain significance (Apr 25, 2023)2049955
3-100713746-A-T Hereditary motor and sensory neuropathy, Okinawa type;Hereditary spastic paraplegia 57 • Inborn genetic diseases Uncertain significance (Jan 12, 2024)1035040
3-100713749-C-T Hereditary motor and sensory neuropathy, Okinawa type;Hereditary spastic paraplegia 57 Pathogenic (Sep 19, 2022)1452866
3-100713753-G-A Hereditary motor and sensory neuropathy, Okinawa type;Hereditary spastic paraplegia 57 • Inborn genetic diseases Uncertain significance (Jan 23, 2024)579063
3-100713753-G-T Uncertain significance (Sep 16, 2019)1217000
3-100713765-A-G Hereditary motor and sensory neuropathy, Okinawa type;Hereditary spastic paraplegia 57 Uncertain significance (Jul 28, 2023)2950416

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TFGprotein_codingprotein_codingENST00000240851 739606
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.1410.859125739081257470.0000318
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.331662220.7480.00001152579
Missense in Polyphen2141.3090.50837530
Synonymous-1.098775.01.160.00000372796
Loss of Function3.31623.20.2590.00000130233

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002920.0000292
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00005330.0000527
Middle Eastern0.000.00
South Asian0.00003360.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Plays a role in the normal dynamic function of the endoplasmic reticulum (ER) and its associated microtubules (PubMed:23479643, PubMed:27813252). {ECO:0000269|PubMed:23479643, ECO:0000269|PubMed:27813252}.;
Disease
DISEASE: Neuropathy, hereditary motor and sensory, Okinawa type (HMSNO) [MIM:604484]: A neurodegenerative disorder characterized by young adult onset of proximal muscle weakness and atrophy, muscle cramps, and fasciculations, with later onset of distal sensory impairment. The disorder is slowly progressive and clinically resembles amyotrophic lateral sclerosis. {ECO:0000269|PubMed:22883144, ECO:0000269|PubMed:27813252}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spastic paraplegia 57, autosomal recessive (SPG57) [MIM:615658]: A complicated form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. Complicated forms are recognized by additional variable features including spastic quadriparesis, seizures, dementia, amyotrophy, extrapyramidal disturbance, cerebral or cerebellar atrophy, optic atrophy, and peripheral neuropathy, as well as by extra neurological manifestations. {ECO:0000269|PubMed:23479643, ECO:0000269|PubMed:27492651, ECO:0000269|PubMed:27813252}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Pathways in cancer - Homo sapiens (human);Thyroid cancer - Homo sapiens (human);Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;EGFR1;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;COPII-mediated vesicle transport;ER to Golgi Anterograde Transport (Consensus)

Recessive Scores

pRec
0.247

Intolerance Scores

loftool
0.391
rvis_EVS
-0.23
rvis_percentile_EVS
37.32

Haploinsufficiency Scores

pHI
0.154
hipred
Y
hipred_score
0.654
ghis
0.594

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
K
gene_indispensability_pred
E
gene_indispensability_score
0.859

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Tfg
Phenotype

Gene ontology

Biological process
endoplasmic reticulum to Golgi vesicle-mediated transport;positive regulation of I-kappaB kinase/NF-kappaB signaling;COPII vesicle coating
Cellular component
Golgi membrane;cytoplasm;cytosol;endoplasmic reticulum exit site
Molecular function
protein binding;identical protein binding